Title |
Experimental validation of FINDSITEcomb virtual ligand screening results for eight proteins yields novel nanomolar and micromolar binders
|
---|---|
Published in |
Journal of Cheminformatics, April 2014
|
DOI | 10.1186/1758-2946-6-16 |
Pubmed ID | |
Authors |
Bharath Srinivasan, Hongyi Zhou, Julia Kubanek, Jeffrey Skolnick |
Abstract |
Identification of ligand-protein binding interactions is a critical step in drug discovery. Experimental screening of large chemical libraries, in spite of their specific role and importance in drug discovery, suffer from the disadvantages of being random, time-consuming and expensive. To accelerate the process, traditional structure- or ligand-based VLS approaches are combined with experimental high-throughput screening, HTS. Often a single protein or, at most, a protein family is considered. Large scale VLS benchmarking across diverse protein families is rarely done, and the reported success rate is very low. Here, we demonstrate the experimental HTS validation of a novel VLS approach, FINDSITE(comb), across a diverse set of medically-relevant proteins. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Germany | 1 | 33% |
Unknown | 2 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Scientists | 1 | 33% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 3% |
Brazil | 1 | 3% |
Unknown | 34 | 94% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 9 | 25% |
Student > Ph. D. Student | 8 | 22% |
Student > Master | 3 | 8% |
Student > Bachelor | 2 | 6% |
Student > Postgraduate | 2 | 6% |
Other | 5 | 14% |
Unknown | 7 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Chemistry | 9 | 25% |
Biochemistry, Genetics and Molecular Biology | 7 | 19% |
Agricultural and Biological Sciences | 6 | 17% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
Mathematics | 1 | 3% |
Other | 4 | 11% |
Unknown | 8 | 22% |